Baldwin Wealth Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-300
Closed -$14.6K 1165
2024
Q2
$14.6K Hold
300
﹤0.01% 505
2024
Q1
$14.6K Hold
300
﹤0.01% 524
2023
Q4
$14.9K Hold
300
﹤0.01% 537
2023
Q3
$16.1K Hold
300
﹤0.01% 534
2023
Q2
$16.2K Hold
300
﹤0.01% 556
2023
Q1
$16.3K Hold
300
﹤0.01% 569
2022
Q4
$14.5K Hold
300
﹤0.01% 570
2022
Q3
$11K Hold
300
﹤0.01% 513
2022
Q2
$15K Hold
300
﹤0.01% 501
2022
Q1
$15K Hold
300
﹤0.01% 507
2021
Q4
$15K Hold
300
﹤0.01% 474
2021
Q3
$14K Hold
300
﹤0.01% 487
2021
Q2
$16K Buy
+300
New +$15.7K ﹤0.01% 491
2019
Q4
Sell
-40
Closed -$2K 554
2019
Q3
$2K Sell
40
-8,255
-100% -$356K ﹤0.01% 501
2019
Q2
$359K Sell
8,295
-2,096
-20% -$89.1K 0.05% 155
2019
Q1
$460K Hold
10,391
0.07% 128
2018
Q4
$451K Hold
10,391
0.08% 124
2018
Q3
$464K Sell
10,391
-730
-7% -$31.2K 0.07% 135
2018
Q2
$445K Hold
11,121
0.07% 134
2018
Q1
$446K Hold
11,121
0.07% 134
2017
Q4
$478K Buy
11,121
+5,742
+107% +$265K 0.07% 130
2017
Q3
$268K Buy
+5,379
New +$260K 0.04% 169

Other funds holding SNY

Baldwin Wealth Partners's SNY Position: Q3 2024 in Review

Baldwin Wealth Partners sold out of Sanofi (SNY) in Q3 2024, closing a stake of 300 shares — an estimated $14.6K sold.

Baldwin Wealth Partners first reported a position in SNY in Q3 2017 and held it in 22 quarters. The position peaked at $478K in Q4 2017. 758 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

  • Baldwin Wealth Partners reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 300 Sanofi shares in Q3 2024, an estimated $14.6K.
  • Baldwin Wealth Partners first reported a position in Sanofi in Q3 2017 and held it in 22 quarters.
  • Baldwin Wealth Partners's Sanofi position peaked at $478K in Q4 2017.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Baldwin Wealth Partners's 13F filing for Q3 2024, filed 16 Oct 2024.